Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
Completed · Phase 1
Conditions studied: Alopecia
In brief
The purpose of this study is to determine if immunophilin ligands may have the potential to reverse hair loss.
Key facts
- Study ID
- NCT00177099
- Run by
- Hordinsky, Maria K., MD
- People needed
- 35
- Starts
- 2003-07-01
- Expected to finish
- 2004-09-01
- Last updated by the study team
- 2006-11-13
Who can join
Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Healthy men ages 18-65 with Hamilton type IV or V alopecia
You may not qualify if…
- Individuals who do not meet the inclusion criteria.
Where it is running
- University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.